HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi Han Selected Research

(Nphe(1),Arg(14),Lys(15))N-OFQ NH(2)

8/2022Antagonism of N/OFQ attenuates externalization of β1-adrenergic receptor and ventricular arrhythmias in acute myocardial ischemia rat model.
12/2019[Endogenous nocciceptin/orphanin FQ affect ischemic arrhythmias in rats through Raf kinase inhibitor protein].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi Han Research Topics

Disease

56Neoplasms (Cancer)
01/2022 - 11/2003
19Infections
01/2022 - 02/2008
15Lung Neoplasms (Lung Cancer)
07/2021 - 11/2005
14Neoplasm Metastasis (Metastasis)
01/2022 - 11/2005
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 10/2006
9COVID-19
01/2022 - 01/2020
8Heart Failure
01/2022 - 04/2012
8Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 10/2009
7Cardiovascular Diseases (Cardiovascular Disease)
04/2021 - 03/2009
7Coronary Artery Disease (Coronary Atherosclerosis)
04/2021 - 01/2010
7Carcinogenesis
01/2021 - 01/2015
7Hypertension (High Blood Pressure)
01/2021 - 01/2010
6Inflammation (Inflammations)
07/2021 - 06/2011
6Ventricular Fibrillation
12/2019 - 02/2010
5Cardiac Arrhythmias (Arrythmia)
08/2022 - 09/2013
5Myocardial Ischemia (Ischemic Heart Diseases)
08/2022 - 04/2011
5Sepsis (Septicemia)
01/2022 - 05/2015
5Type 2 Diabetes Mellitus (MODY)
04/2021 - 07/2011
5Obesity
01/2021 - 01/2017
5Hypertrophy
01/2021 - 04/2012
5Atherosclerosis
01/2021 - 06/2011
5Hepatocellular Carcinoma (Hepatoma)
12/2020 - 08/2018
4Liver Diseases (Liver Disease)
06/2022 - 01/2018
4Fibrosis (Cirrhosis)
12/2021 - 02/2008
4Pneumonia (Pneumonitis)
11/2021 - 01/2020
4Orthomyxoviridae Infections
01/2021 - 01/2020
4Lymphatic Metastasis
08/2018 - 11/2008
4Postoperative Pain
08/2015 - 08/2013
4Endometriosis
08/2015 - 04/2010
3Hemorrhage
01/2022 - 01/2013
3Breast Neoplasms (Breast Cancer)
01/2022 - 09/2008
3Flatulence
01/2021 - 05/2012
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 01/2020
3Cholangiocarcinoma
01/2021 - 10/2020
3Human Influenza (Influenza)
01/2021 - 03/2020
3Hyperglycemia
01/2021 - 01/2006
3Pain (Aches)
01/2021 - 04/2009
3Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 08/2019
3Tuberculosis (Tuberculoses)
01/2020 - 01/2017
3Reperfusion Injury
01/2017 - 01/2014
3Atherosclerotic Plaque (Atheroma)
10/2016 - 01/2013
3Necrosis
06/2016 - 02/2008
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2014 - 11/2005
3Adenocarcinoma
01/2014 - 11/2005
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
02/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2006
16Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2012
16Messenger RNA (mRNA)IBA
01/2022 - 11/2005
14Pharmaceutical PreparationsIBA
03/2022 - 09/2005
6Therapeutic UsesIBA
03/2022 - 03/2009
6Hydrogen Sulfide (Sulfide, Hydrogen)IBA
04/2020 - 08/2013
5AntioxidantsIBA
01/2022 - 01/2013
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2006
5Long Noncoding RNAIBA
01/2021 - 01/2018
4LipidsIBA
01/2022 - 12/2016
4Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 02/2015
4LipopolysaccharidesIBA
01/2022 - 06/2016
4VaccinesIBA
02/2021 - 01/2020
4AntibodiesIBA
01/2021 - 05/2020
4CateninsIBA
01/2020 - 11/2014
4MicroRNAs (MicroRNA)IBA
01/2020 - 07/2018
4Estrogens (Estrogen)FDA Link
01/2016 - 04/2010
4Gonadotropin-Releasing Hormone (GnRH)FDA Link
08/2015 - 04/2010
3Adrenergic Agents (Adrenergic Drugs)IBA
08/2022 - 04/2011
3Phosphotransferases (Kinase)IBA
01/2022 - 01/2021
3Peptides (Polypeptides)IBA
01/2022 - 04/2011
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2019
3Membrane Proteins (Integral Membrane Proteins)IBA
01/2022 - 07/2016
3Indicators and Reagents (Reagents)IBA
07/2021 - 01/2021
3C-Reactive ProteinIBA
07/2021 - 06/2020
3ProcalcitoninIBA
07/2021 - 06/2020
3Small Interfering RNA (siRNA)IBA
01/2021 - 07/2014
3ChitosanIBA
01/2021 - 01/2020
3CytokinesIBA
01/2021 - 08/2014
3NanovaccinesIBA
01/2021 - 01/2020
3GYY 4137IBA
01/2021 - 08/2013
3Circular RNAIBA
01/2021 - 01/2020
3Choline (Choline Chloride)IBA
01/2021 - 01/2018
3NeuropeptidesIBA
06/2020 - 01/2020
3AntigensIBA
05/2020 - 01/2020
3Poly I-CIBA
05/2020 - 01/2020
3EnzymesIBA
01/2020 - 11/2005
3Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2017 - 01/2010
3Norepinephrine (Noradrenaline)FDA LinkGeneric
09/2013 - 02/2010
3Apolipoproteins E (ApoE)IBA
08/2013 - 01/2013
3GlucokinaseIBA
06/2006 - 04/2005
2NociceptinIBA
08/2022 - 12/2019
2(Nphe(1),Arg(14),Lys(15))N-OFQ NH(2)IBA
08/2022 - 12/2019
2Phosphates (Orthophosphate)IBA
01/2022 - 10/2019

Therapy/Procedure

18Therapeutics
01/2022 - 11/2012
6Drug Therapy (Chemotherapy)
01/2022 - 10/2006
5Immunotherapy
02/2021 - 12/2019
5Length of Stay
01/2021 - 11/2012
5Cardiopulmonary Resuscitation (CPR)
02/2013 - 02/2010
4Ligation
03/2021 - 01/2019
4Thoracotomy
01/2019 - 08/2015
4Operative Time
12/2014 - 12/2010
3Punctures
03/2021 - 01/2019
3Operative Surgical Procedures
10/2007 - 11/2003
2Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2022 - 03/2021